Company intelligence
Meowsprout Therapeutics
Digital Medicines, AI Child Developmental Platform
Education
Vancouver, CA
2–10 employees
Founded 2023
4 public signals
About Meowsprout Therapeutics
Meowsprout is a Neuro-AI platform company focused on child brain development. Grounded in neuroscience and AI, Meowsprout builds long-term, continuously operating digital systems to understand, track, and support children’s brain development across the dimensions of Learning, Behavior, and Health (LBH).
Verified activity
Signals from Meowsprout Therapeutics
4 published signals
Products & Services
Meowsprout Therapeutics highlighted that child safety is moving into product architecture with age assurance, parental controls, usage boundaries, notification design, and non-addictive interaction patterns becoming procurement and liability questions.
Reported by Andy Yu
Research & Knowledge
Meowsprout Therapeutics noted that evidence is becoming a go-to-market asset and that education buyers and health regulators are converging on a defined context of use, measurable outcomes, transparent data practices, and continuous validation.
Reported by Andy Yu
Research & Knowledge
Meowsprout Therapeutics announced that FDA and Duke-Margolis convened an August 27 workshop on clinically meaningful digitally derived endpoints, data standards, analytical methods, and regulatory submissions.
Reported by Andy Yu